Active Ingredient History

  • Now
Entacapone is a selective, reversible catechol-O-methyl transferase (COMT) inhibitor for the treatment of Parkinson's disease. It is a member of the class of nitrocatechols. When administered concomittantly with levodopa and a decarboxylase inhibitor (e.g., carbidopa), increased and more sustained plasma levodopa concentrations are reached as compared to the administration of levodopa and a decarboxylase inhibitor. The mechanism of action of entacapone is believed to be through its ability to inhibit COMT in peripheral tissues, altering the plasma pharmacokinetics of levodopa. When entacapone is given in conjunction with levodopa and an aromatic amino acid decarboxylase inhibitor, such as carbidopa, plasma levels of levodopa are greater and more sustained than after administration of levodopa and an aromatic amino acid decarboxylase inhibitor alone. It is believed that at a given frequency of levodopa administration, these more sustained plasma levels of levodopa result in more constant dopaminergic stimulation in the brain, leading to a greater reduction in the manifestations of parkinsonian syndrome. Entacapone is used as an adjunct to levodopa / carbidopa in the symptomatic treatment of patients with idiopathic Parkinson's Disease who experience the signs and symptoms of end-of-dose "wearing-off".   NCATS

  • SMILES: CCN(CC)C(=O)C(\C#N)=C\C1=CC(O)=C(O)C(=C1)[N+]([O-])=O
  • Mol. Mass: 305.286
  • ALogP: 1.78
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$0.0001 - $7.5874
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

2-cyano-n,n-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide | comtan | comtess | (e)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-n,n-diethyl-prop-2-enamide | (e)-alpha-cyano-n,n-diethyl-3,4-dihydroxy-5-nitrocinnamamide | entacapona | entacapone | entacaponum | entacom | levodopa / carbidopa / entacapone | n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide | novartis brand of entacapone | or 611 | or-611 | orion brand of entacapone


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue